| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.73e-14 | 37 | 28 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 5.79e-14 | 38 | 28 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-8 ADAMTS12 BMP1 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 TLL1 TLL2 | 6.28e-12 | 430 | 28 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-8 ADAMTS12 BMP1 ERVK-19 RELN ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 TLL1 TLL2 | 2.60e-11 | 654 | 28 | 12 | GO:0008233 |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-8 CRELD1 ERVK-19 RELN ERVK-7 ERVK-21 FBN1 ERVK-9 ERVK-10 ERVK-24 OC90 | 1.40e-08 | 891 | 28 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-8 BMP1 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 PHF5A TLL1 TLL2 | 1.40e-08 | 891 | 28 | 11 | GO:0008270 |
| GeneOntologyMolecularFunction | calcium ion binding | 3.69e-08 | 749 | 28 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-8 BMP1 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 PHF5A TLL1 TLL2 | 2.67e-07 | 1189 | 28 | 11 | GO:0046914 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 4.04e-07 | 11 | 28 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 8.90e-07 | 14 | 28 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.23e-06 | 21 | 28 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.86e-05 | 37 | 28 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.02e-05 | 38 | 28 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 2.27e-05 | 120 | 28 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.60e-05 | 46 | 28 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.66e-04 | 200 | 28 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.82e-04 | 79 | 28 | 3 | GO:0004521 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.89e-04 | 207 | 28 | 4 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 2.07e-04 | 212 | 28 | 4 | GO:0017171 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 8.94e-04 | 136 | 28 | 3 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 8.94e-04 | 136 | 28 | 3 | GO:0004519 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.23e-03 | 152 | 28 | 3 | GO:0016779 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.26e-03 | 188 | 28 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 2.33e-03 | 190 | 28 | 3 | GO:0004252 | |
| GeneOntologyMolecularFunction | nuclease activity | 4.04e-03 | 231 | 28 | 3 | GO:0004518 | |
| GeneOntologyMolecularFunction | collagen binding | 5.74e-03 | 81 | 28 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.74e-03 | 262 | 28 | 3 | GO:0140097 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 9.03e-03 | 938 | 28 | 5 | GO:0016772 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 9.92e-03 | 1353 | 28 | 6 | GO:0004888 | |
| GeneOntologyBiologicalProcess | DNA integration | 5.67e-07 | 13 | 27 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | viral process | 1.68e-06 | 464 | 27 | 7 | GO:0016032 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 2.80e-06 | 76 | 27 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 4.38e-06 | 85 | 27 | 4 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 4.38e-06 | 85 | 27 | 4 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 5.27e-06 | 89 | 27 | 4 | GO:0006949 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 2.47e-05 | 6 | 27 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 2.47e-05 | 6 | 27 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | regionalization | 2.94e-05 | 478 | 27 | 6 | GO:0003002 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.33e-05 | 48 | 27 | 3 | GO:0000731 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 3.45e-05 | 7 | 27 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 3.45e-05 | 7 | 27 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | pattern specification process | 5.01e-05 | 526 | 27 | 6 | GO:0007389 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | ERVK-8 ERVK-19 RELN CELSR1 ERVK-21 ERVK-9 ITGB2 NOTCH2 NOTCH3 | 7.16e-05 | 1483 | 27 | 9 | GO:0048646 |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 9.01e-05 | 11 | 27 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.15e-04 | 377 | 27 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.17e-04 | 378 | 27 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.18e-04 | 379 | 27 | 5 | GO:0045229 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.19e-04 | 615 | 27 | 6 | GO:0001501 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast development | 1.28e-04 | 13 | 27 | 2 | GO:2001204 | |
| GeneOntologyBiologicalProcess | regulation of cartilage development | 1.59e-04 | 81 | 27 | 3 | GO:0061035 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.71e-04 | 83 | 27 | 3 | GO:0006278 | |
| GeneOntologyBiologicalProcess | motor neuron migration | 1.71e-04 | 15 | 27 | 2 | GO:0097475 | |
| GeneOntologyBiologicalProcess | dorsal/ventral pattern formation | 3.63e-04 | 107 | 27 | 3 | GO:0009953 | |
| GeneOntologyBiologicalProcess | bone development | 3.65e-04 | 264 | 27 | 4 | GO:0060348 | |
| GeneOntologyBiologicalProcess | osteoclast development | 3.75e-04 | 22 | 27 | 2 | GO:0036035 | |
| GeneOntologyBiologicalProcess | bone cell development | 3.75e-04 | 22 | 27 | 2 | GO:0098751 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 4.59e-04 | 116 | 27 | 3 | GO:0045670 | |
| GeneOntologyBiologicalProcess | axon guidance | 4.87e-04 | 285 | 27 | 4 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 4.94e-04 | 286 | 27 | 4 | GO:0097485 | |
| GeneOntologyBiologicalProcess | negative regulation of chondrocyte differentiation | 5.68e-04 | 27 | 27 | 2 | GO:0032331 | |
| GeneOntologyBiologicalProcess | bone remodeling | 5.98e-04 | 127 | 27 | 3 | GO:0046849 | |
| GeneOntologyBiologicalProcess | positive regulation of bone resorption | 6.11e-04 | 28 | 27 | 2 | GO:0045780 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 7.02e-04 | 30 | 27 | 2 | GO:0072012 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 7.50e-04 | 31 | 27 | 2 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 7.50e-04 | 31 | 27 | 2 | GO:0061437 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 8.28e-04 | 142 | 27 | 3 | GO:0018958 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 1.01e-03 | 36 | 27 | 2 | GO:0061037 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 1.05e-03 | 350 | 27 | 4 | GO:0045860 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 1.21e-03 | 162 | 27 | 3 | GO:0030316 | |
| GeneOntologyBiologicalProcess | positive regulation of osteoclast differentiation | 1.51e-03 | 44 | 27 | 2 | GO:0045672 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 1.59e-03 | 178 | 27 | 3 | GO:0006261 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 1.69e-03 | 182 | 27 | 3 | GO:0002761 | |
| GeneOntologyBiologicalProcess | tube development | 1.75e-03 | 1402 | 27 | 7 | GO:0035295 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.80e-03 | 405 | 27 | 4 | GO:0033674 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | 1.81e-03 | 1028 | 27 | 6 | GO:0043085 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | 1.97e-03 | 1430 | 27 | 7 | GO:0044093 | |
| GeneOntologyBiologicalProcess | icosanoid secretion | 2.43e-03 | 56 | 27 | 2 | GO:0032309 | |
| GeneOntologyBiologicalProcess | regulation of chondrocyte differentiation | 2.70e-03 | 59 | 27 | 2 | GO:0032330 | |
| GeneOntologyBiologicalProcess | response to BMP | 2.72e-03 | 215 | 27 | 3 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 2.72e-03 | 215 | 27 | 3 | GO:0071773 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 2.82e-03 | 218 | 27 | 3 | GO:0071897 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 2.88e-03 | 61 | 27 | 2 | GO:1902895 | |
| GeneOntologyBiologicalProcess | activated T cell proliferation | 3.26e-03 | 65 | 27 | 2 | GO:0050798 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.93e-05 | 656 | 28 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.97e-05 | 658 | 28 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | cell surface | 5.20e-04 | 1111 | 28 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 6.23e-04 | 530 | 28 | 5 | GO:0062023 | |
| HumanPheno | Fifth metacarpal with ulnar notch | 6.01e-06 | 2 | 13 | 2 | HP:0005900 | |
| HumanPheno | Abnormal form of the vertebral bodies | 7.84e-06 | 348 | 13 | 7 | HP:0003312 | |
| HumanPheno | Abnormal vertebral morphology | 6.82e-05 | 483 | 13 | 7 | HP:0003468 | |
| HumanPheno | Abnormality of skull ossification | 6.85e-05 | 94 | 13 | 4 | HP:0002703 | |
| HumanPheno | Abnormal metaphysis morphology | 1.04e-04 | 344 | 13 | 6 | HP:0000944 | |
| HumanPheno | Abnormality of cranial sutures | 2.03e-04 | 388 | 13 | 6 | HP:0011329 | |
| HumanPheno | Long eyelashes | 2.35e-04 | 129 | 13 | 4 | HP:0000527 | |
| HumanPheno | Abnormal pulmonary artery morphology | 2.64e-04 | 133 | 13 | 4 | HP:0030966 | |
| HumanPheno | Abnormal morphology of bones of the lower limbs | 3.24e-04 | 422 | 13 | 6 | HP:0040066 | |
| HumanPheno | Long philtrum | 3.54e-04 | 429 | 13 | 6 | HP:0000343 | |
| HumanPheno | Abnormal lower limb bone morphology | 3.89e-04 | 866 | 13 | 8 | HP:0040069 | |
| HumanPheno | Wormian bones | 4.29e-04 | 61 | 13 | 3 | HP:0002645 | |
| HumanPheno | Transient ischemic attack | 4.29e-04 | 61 | 13 | 3 | HP:0002326 | |
| HumanPheno | Anterior bulging of the globe | 4.54e-04 | 283 | 13 | 5 | HP:0000644 | |
| HumanPheno | Proptosis | 4.54e-04 | 283 | 13 | 5 | HP:0000520 | |
| HumanPheno | Abnormal eyelash morphology | 4.62e-04 | 284 | 13 | 5 | HP:0000499 | |
| HumanPheno | Pulmonary artery dilatation | 5.38e-04 | 14 | 13 | 2 | HP:0004927 | |
| HumanPheno | Abnormal cranial suture/fontanelle morphology | 5.97e-04 | 472 | 13 | 6 | HP:0000235 | |
| HumanPheno | Abnormal sternum morphology | 6.11e-04 | 474 | 13 | 6 | HP:0000766 | |
| HumanPheno | Abnormal femur morphology | 6.33e-04 | 304 | 13 | 5 | HP:0002823 | |
| HumanPheno | Umbilical hernia | 6.53e-04 | 306 | 13 | 5 | HP:0001537 | |
| HumanPheno | Sclerosis of skull base | 7.07e-04 | 16 | 13 | 2 | HP:0002694 | |
| HumanPheno | Abnormal umbilicus morphology | 7.24e-04 | 313 | 13 | 5 | HP:0001551 | |
| HumanPheno | Platybasia | 8.00e-04 | 17 | 13 | 2 | HP:0002691 | |
| HumanPheno | Pectus carinatum | 8.05e-04 | 178 | 13 | 4 | HP:0000768 | |
| HumanPheno | Abnormality of the thigh | 8.25e-04 | 322 | 13 | 5 | HP:0001439 | |
| HumanPheno | Abnormal mitral valve physiology | 8.39e-04 | 180 | 13 | 4 | HP:0031481 | |
| HumanPheno | Hernia of the abdominal wall | 8.70e-04 | 506 | 13 | 6 | HP:0004299 | |
| HumanPheno | Abnormality of external features of the abdomen | 8.73e-04 | 326 | 13 | 5 | HP:0001462 | |
| HumanPheno | Shallow anterior chamber | 8.99e-04 | 18 | 13 | 2 | HP:0000594 | |
| HumanPheno | Abnormality of the philtrum | 9.10e-04 | 726 | 13 | 7 | HP:0000288 | |
| HumanPheno | Abdominal wall defect | 9.17e-04 | 511 | 13 | 6 | HP:0010866 | |
| HumanPheno | Thoracoabdominal wall defect | 9.17e-04 | 511 | 13 | 6 | HP:0100656 | |
| HumanPheno | Hypoplastic facial bones | 9.36e-04 | 331 | 13 | 5 | HP:0002692 | |
| HumanPheno | Aplasia/Hypoplasia of facial bones | 9.50e-04 | 332 | 13 | 5 | HP:0034261 | |
| HumanPheno | Hypercalcemia | 9.88e-04 | 81 | 13 | 3 | HP:0003072 | |
| HumanPheno | Elbow dislocation | 1.10e-03 | 84 | 13 | 3 | HP:0003042 | |
| HumanPheno | Osteolysis | 1.10e-03 | 84 | 13 | 3 | HP:0002797 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | 1.14e-03 | 1008 | 13 | 8 | HP:0009122 | |
| HumanPheno | Kyphoscoliosis | 1.16e-03 | 196 | 13 | 4 | HP:0002751 | |
| HumanPheno | Abnormal atrioventricular valve morphology | 1.21e-03 | 350 | 13 | 5 | HP:0006705 | |
| HumanPheno | Abnormality of the dentition | 1.32e-03 | 1030 | 13 | 8 | HP:0000164 | |
| HumanPheno | Abnormal 5th metacarpal morphology | 1.35e-03 | 22 | 13 | 2 | HP:0010013 | |
| HumanPheno | Broad forehead | 1.37e-03 | 205 | 13 | 4 | HP:0000337 | |
| HumanPheno | Joint hypermobility | 1.45e-03 | 557 | 13 | 6 | HP:0001382 | |
| HumanPheno | Abnormal cardiac septum morphology | 1.49e-03 | 787 | 13 | 7 | HP:0001671 | |
| HumanPheno | Abnormality of the abdominal wall | 1.50e-03 | 560 | 13 | 6 | HP:0004298 | |
| HumanPheno | Enlarged thorax | 1.52e-03 | 94 | 13 | 3 | HP:0100625 | |
| HumanPheno | Subcutaneous nodule | 1.57e-03 | 95 | 13 | 3 | HP:0001482 | |
| HumanPheno | Dural ectasia | 1.61e-03 | 24 | 13 | 2 | HP:0100775 | |
| HumanPheno | Coarse metaphyseal trabecularization | 1.61e-03 | 24 | 13 | 2 | HP:0100670 | |
| HumanPheno | Thin bony cortex | 1.61e-03 | 24 | 13 | 2 | HP:0002753 | |
| HumanPheno | Upper extremity joint dislocation | 1.62e-03 | 96 | 13 | 3 | HP:0030310 | |
| HumanPheno | Abnormal atrioventricular valve physiology | 1.63e-03 | 215 | 13 | 4 | HP:0031650 | |
| HumanPheno | Abnormal metaphyseal trabeculation | 1.75e-03 | 25 | 13 | 2 | HP:0005089 | |
| HumanPheno | Biconcave vertebral bodies | 1.75e-03 | 25 | 13 | 2 | HP:0004586 | |
| HumanPheno | Abnormal spinal meningeal morphology | 1.75e-03 | 25 | 13 | 2 | HP:0010303 | |
| HumanPheno | Dolichocephaly | 1.75e-03 | 219 | 13 | 4 | HP:0000268 | |
| HumanPheno | Mandibular prognathia | 1.75e-03 | 219 | 13 | 4 | HP:0000303 | |
| HumanPheno | Abnormal long bone morphology | 1.93e-03 | 821 | 13 | 7 | HP:0011314 | |
| HumanPheno | Abnormal heart valve morphology | 1.94e-03 | 588 | 13 | 6 | HP:0001654 | |
| HumanPheno | Abnormality of bone mineral density | 1.95e-03 | 822 | 13 | 7 | HP:0004348 | |
| HumanPheno | Hernia | 1.95e-03 | 589 | 13 | 6 | HP:0100790 | |
| HumanPheno | Abnormal peripheral nervous system morphology | 1.98e-03 | 1395 | 13 | 9 | HP:0000759 | |
| HumanPheno | Abnormal bone ossification | 2.02e-03 | 827 | 13 | 7 | HP:0011849 | |
| HumanPheno | Mitral stenosis | 2.19e-03 | 28 | 13 | 2 | HP:0001718 | |
| HumanPheno | Chiari malformation | 2.21e-03 | 107 | 13 | 3 | HP:0002308 | |
| HumanPheno | Narrow mouth | 2.23e-03 | 234 | 13 | 4 | HP:0000160 | |
| HumanPheno | Abnormality of the chin | 2.44e-03 | 409 | 13 | 5 | HP:0000306 | |
| HumanPheno | Malar flattening | 2.45e-03 | 240 | 13 | 4 | HP:0000272 | |
| HumanPheno | Severe short stature | 2.46e-03 | 111 | 13 | 3 | HP:0003510 | |
| HumanPheno | Abnormal malar bone morphology | 2.81e-03 | 249 | 13 | 4 | HP:0012369 | |
| HumanPheno | Abnormal zygomatic arch morphology | 2.85e-03 | 250 | 13 | 4 | HP:0005557 | |
| MousePheno | abnormal long bone metaphysis morphology | 1.95e-07 | 39 | 19 | 4 | MP:0000133 | |
| MousePheno | abnormal trabecular bone morphology | 1.60e-06 | 289 | 19 | 6 | MP:0000130 | |
| MousePheno | abnormal bone remodeling | 3.18e-06 | 178 | 19 | 5 | MP:0002998 | |
| MousePheno | increased osteoblast cell number | 1.74e-05 | 38 | 19 | 3 | MP:0004988 | |
| MousePheno | abnormal bone trabecula morphology | 2.80e-05 | 134 | 19 | 4 | MP:0010867 | |
| MousePheno | abnormal bone volume | 7.59e-05 | 173 | 19 | 4 | MP:0010874 | |
| MousePheno | misaligned incisors | 7.83e-05 | 10 | 19 | 2 | MP:0030541 | |
| MousePheno | decreased bone trabecula number | 1.10e-04 | 70 | 19 | 3 | MP:0010869 | |
| MousePheno | abnormal enamel organ morphology | 1.15e-04 | 12 | 19 | 2 | MP:0010747 | |
| MousePheno | abnormal skeleton physiology | 1.36e-04 | 632 | 19 | 6 | MP:0001533 | |
| MousePheno | abnormal osteoblast cell number | 1.46e-04 | 77 | 19 | 3 | MP:0004987 | |
| MousePheno | increased osteoclast cell number | 1.46e-04 | 77 | 19 | 3 | MP:0004984 | |
| MousePheno | osteosclerosis | 1.58e-04 | 14 | 19 | 2 | MP:0005422 | |
| MousePheno | decreased compact bone thickness | 1.83e-04 | 83 | 19 | 3 | MP:0000135 | |
| MousePheno | abnormal type IV hypersensitivity reaction | 1.83e-04 | 83 | 19 | 3 | MP:0002534 | |
| MousePheno | abnormal osteoclast differentiation | 1.96e-04 | 85 | 19 | 3 | MP:0008396 | |
| MousePheno | abnormal long bone morphology | 1.97e-04 | 676 | 19 | 6 | MP:0003723 | |
| MousePheno | decreased trabecular bone connectivity density | 2.08e-04 | 16 | 19 | 2 | MP:0010933 | |
| MousePheno | kyphosis | 2.24e-04 | 229 | 19 | 4 | MP:0000160 | |
| MousePheno | craniofacial phenotype | 2.37e-04 | 1372 | 19 | 8 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 2.37e-04 | 1372 | 19 | 8 | MP:0000428 | |
| MousePheno | decreased bone volume | 3.17e-04 | 100 | 19 | 3 | MP:0010876 | |
| MousePheno | abnormal skin morphology | 3.56e-04 | 1455 | 19 | 8 | MP:0002060 | |
| MousePheno | abnormal axial skeleton morphology | 3.61e-04 | 1458 | 19 | 8 | MP:0002114 | |
| MousePheno | abnormal blood vessel morphology | 3.86e-04 | 1472 | 19 | 8 | MP:0001614 | |
| MousePheno | abnormal tooth development | 3.97e-04 | 108 | 19 | 3 | MP:0000116 | |
| MousePheno | abnormal incisor morphology | 4.19e-04 | 110 | 19 | 3 | MP:0005358 | |
| MousePheno | abnormal vertebral column morphology | 4.50e-04 | 787 | 19 | 6 | MP:0004703 | |
| MousePheno | abnormal trabecular bone volume | 4.53e-04 | 113 | 19 | 3 | MP:0010877 | |
| MousePheno | abnormal macrophage cell number | 4.69e-04 | 278 | 19 | 4 | MP:0020202 | |
| MousePheno | abnormal cranium morphology | 5.36e-04 | 813 | 19 | 6 | MP:0000438 | |
| MousePheno | abnormal compact bone thickness | 5.67e-04 | 122 | 19 | 3 | MP:0000134 | |
| MousePheno | abnormal tumor morphology | 5.67e-04 | 122 | 19 | 3 | MP:0003448 | |
| MousePheno | abnormal craniofacial bone morphology | 5.87e-04 | 827 | 19 | 6 | MP:0002116 | |
| MousePheno | abnormal trabecular bone connectivity density | 6.02e-04 | 27 | 19 | 2 | MP:0010931 | |
| MousePheno | abnormal osteoclast cell number | 6.53e-04 | 128 | 19 | 3 | MP:0004983 | |
| MousePheno | abnormal mature B cell number | 7.24e-04 | 312 | 19 | 4 | MP:0013701 | |
| MousePheno | abnormal spine curvature | 7.77e-04 | 318 | 19 | 4 | MP:0004174 | |
| MousePheno | abnormal osteoblast morphology | 7.95e-04 | 137 | 19 | 3 | MP:0004986 | |
| MousePheno | increased bone ossification | 8.47e-04 | 32 | 19 | 2 | MP:0020039 | |
| MousePheno | enlarged testis | 8.83e-04 | 142 | 19 | 3 | MP:0001148 | |
| MousePheno | abnormal appendicular skeleton morphology | 8.97e-04 | 896 | 19 | 6 | MP:0009250 | |
| MousePheno | abnormal viscerocranium morphology | 9.57e-04 | 593 | 19 | 5 | MP:0005274 | |
| MousePheno | aneurysm | 1.01e-03 | 35 | 19 | 2 | MP:0003279 | |
| MousePheno | abnormal bronchiole morphology | 1.13e-03 | 37 | 19 | 2 | MP:0002267 | |
| MousePheno | increased macrophage cell number | 1.29e-03 | 162 | 19 | 3 | MP:0005425 | |
| MousePheno | increased neutrophil cell number | 1.34e-03 | 368 | 19 | 4 | MP:0000219 | |
| MousePheno | abnormal mitral valve morphology | 1.39e-03 | 41 | 19 | 2 | MP:0000286 | |
| MousePheno | abnormal bone mineral density | 1.46e-03 | 652 | 19 | 5 | MP:0010119 | |
| MousePheno | abnormal compact bone morphology | 1.53e-03 | 172 | 19 | 3 | MP:0003797 | |
| MousePheno | abnormal hypersensitivity reaction | 1.59e-03 | 174 | 19 | 3 | MP:0002148 | |
| MousePheno | abnormal tumor pathology | 1.64e-03 | 176 | 19 | 3 | MP:0010639 | |
| MousePheno | abnormal trabecular bone mass | 1.67e-03 | 45 | 19 | 2 | MP:0010871 | |
| MousePheno | abnormal bone ossification | 1.74e-03 | 395 | 19 | 4 | MP:0008271 | |
| MousePheno | abnormal bone mineralization | 1.78e-03 | 181 | 19 | 3 | MP:0002896 | |
| MousePheno | malocclusion | 1.82e-03 | 47 | 19 | 2 | MP:0000120 | |
| MousePheno | decreased bone mineral density of femur | 1.82e-03 | 47 | 19 | 2 | MP:0020010 | |
| MousePheno | abnormal osteoclast morphology | 1.83e-03 | 183 | 19 | 3 | MP:0004982 | |
| MousePheno | abnormal bone trabecular spacing | 1.90e-03 | 48 | 19 | 2 | MP:0013629 | |
| MousePheno | increased tumor growth/size | 1.90e-03 | 48 | 19 | 2 | MP:0003721 | |
| MousePheno | abnormal T-helper 1 cell morphology | 1.90e-03 | 48 | 19 | 2 | MP:0002433 | |
| MousePheno | premature death | 2.06e-03 | 1051 | 19 | 6 | MP:0002083 | |
| MousePheno | abnormal eye vasculature morphology | 2.08e-03 | 415 | 19 | 4 | MP:0031346 | |
| MousePheno | misaligned teeth | 2.23e-03 | 52 | 19 | 2 | MP:0030540 | |
| MousePheno | abnormal vitreous body morphology | 2.35e-03 | 429 | 19 | 4 | MP:0002699 | |
| MousePheno | abnormal skeleton development | 2.73e-03 | 447 | 19 | 4 | MP:0002113 | |
| MousePheno | decreased susceptibility to type IV hypersensitivity reaction | 2.86e-03 | 59 | 19 | 2 | MP:0005616 | |
| MousePheno | decreased trabecular bone volume | 2.96e-03 | 60 | 19 | 2 | MP:0010879 | |
| MousePheno | abnormal macrophage morphology | 3.10e-03 | 463 | 19 | 4 | MP:0002446 | |
| MousePheno | abnormal bone mineral density of femur | 3.25e-03 | 63 | 19 | 2 | MP:0020009 | |
| MousePheno | abnormal skin condition | 3.38e-03 | 227 | 19 | 3 | MP:0001191 | |
| MousePheno | decreased bone mineral density | 3.42e-03 | 476 | 19 | 4 | MP:0000063 | |
| MousePheno | abnormal respiratory epithelium morphology | 3.72e-03 | 235 | 19 | 3 | MP:0010942 | |
| MousePheno | abnormal atrioventricular valve morphology | 3.89e-03 | 69 | 19 | 2 | MP:0002745 | |
| MousePheno | abnormal neutrophil cell number | 4.06e-03 | 499 | 19 | 4 | MP:0012440 | |
| Domain | EGF_1 | BMP1 CRELD1 RELN CELSR1 LTBP3 FBN1 ITGB2 TLL1 TLL2 NOTCH2 NOTCH3 | 7.74e-16 | 255 | 21 | 11 | PS00022 |
| Domain | EGF-like_CS | BMP1 CRELD1 RELN CELSR1 LTBP3 FBN1 ITGB2 TLL1 TLL2 NOTCH2 NOTCH3 | 1.00e-15 | 261 | 21 | 11 | IPR013032 |
| Domain | EGF_2 | BMP1 CRELD1 RELN CELSR1 LTBP3 FBN1 ITGB2 TLL1 TLL2 NOTCH2 NOTCH3 | 1.19e-15 | 265 | 21 | 11 | PS01186 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.20e-15 | 106 | 21 | 9 | IPR000152 | |
| Domain | EGF_CA | 4.41e-15 | 122 | 21 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.13e-15 | 124 | 21 | 9 | IPR001881 | |
| Domain | EGF_3 | 2.57e-14 | 235 | 21 | 10 | PS50026 | |
| Domain | EGF | 2.57e-14 | 235 | 21 | 10 | SM00181 | |
| Domain | EGF_CA | 2.81e-14 | 86 | 21 | 8 | PF07645 | |
| Domain | EGF-like_dom | 4.59e-14 | 249 | 21 | 10 | IPR000742 | |
| Domain | EGF_Ca-bd_CS | 7.59e-14 | 97 | 21 | 8 | IPR018097 | |
| Domain | EGF_CA | 8.98e-14 | 99 | 21 | 8 | PS01187 | |
| Domain | Growth_fac_rcpt_ | 3.67e-12 | 156 | 21 | 8 | IPR009030 | |
| Domain | ASX_HYDROXYL | 1.11e-11 | 100 | 21 | 7 | PS00010 | |
| Domain | BMP_1/tolloid-like | 1.23e-09 | 3 | 21 | 3 | IPR015446 | |
| Domain | EGF | 4.18e-09 | 126 | 21 | 6 | PF00008 | |
| Domain | Peptidase_M12A | 2.44e-08 | 6 | 21 | 3 | IPR001506 | |
| Domain | Astacin | 2.44e-08 | 6 | 21 | 3 | PF01400 | |
| Domain | MetalloPept_cat_dom | 1.86e-06 | 81 | 21 | 4 | IPR024079 | |
| Domain | - | 1.86e-06 | 81 | 21 | 4 | 3.40.390.10 | |
| Domain | DUF3454 | 3.61e-06 | 3 | 21 | 2 | PF11936 | |
| Domain | DUF3454_notch | 3.61e-06 | 3 | 21 | 2 | IPR024600 | |
| Domain | DUF3454 | 3.61e-06 | 3 | 21 | 2 | SM01334 | |
| Domain | hEGF | 3.94e-06 | 28 | 21 | 3 | PF12661 | |
| Domain | ZINC_PROTEASE | 3.98e-06 | 98 | 21 | 4 | PS00142 | |
| Domain | ZnMc | 4.39e-06 | 29 | 21 | 3 | SM00235 | |
| Domain | Peptidase_Metallo | 4.39e-06 | 29 | 21 | 3 | IPR006026 | |
| Domain | NOD | 7.21e-06 | 4 | 21 | 2 | PF06816 | |
| Domain | Notch | 7.21e-06 | 4 | 21 | 2 | IPR008297 | |
| Domain | NODP | 7.21e-06 | 4 | 21 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 7.21e-06 | 4 | 21 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 7.21e-06 | 4 | 21 | 2 | IPR010660 | |
| Domain | NOD | 7.21e-06 | 4 | 21 | 2 | SM01338 | |
| Domain | NODP | 7.21e-06 | 4 | 21 | 2 | SM01339 | |
| Domain | LNR | 1.20e-05 | 5 | 21 | 2 | PS50258 | |
| Domain | CUB | 2.18e-05 | 49 | 21 | 3 | PF00431 | |
| Domain | CUB | 2.32e-05 | 50 | 21 | 3 | SM00042 | |
| Domain | Notch_dom | 2.52e-05 | 7 | 21 | 2 | IPR000800 | |
| Domain | Notch | 2.52e-05 | 7 | 21 | 2 | PF00066 | |
| Domain | TB | 2.52e-05 | 7 | 21 | 2 | PF00683 | |
| Domain | NL | 2.52e-05 | 7 | 21 | 2 | SM00004 | |
| Domain | - | 2.61e-05 | 52 | 21 | 3 | 2.60.120.290 | |
| Domain | CUB | 2.77e-05 | 53 | 21 | 3 | PS01180 | |
| Domain | - | 3.36e-05 | 8 | 21 | 2 | 3.90.290.10 | |
| Domain | CUB_dom | 3.45e-05 | 57 | 21 | 3 | IPR000859 | |
| Domain | EGF_extracell | 4.02e-05 | 60 | 21 | 3 | IPR013111 | |
| Domain | EGF_2 | 4.02e-05 | 60 | 21 | 3 | PF07974 | |
| Domain | TB | 4.31e-05 | 9 | 21 | 2 | PS51364 | |
| Domain | TB_dom | 4.31e-05 | 9 | 21 | 2 | IPR017878 | |
| Domain | cEGF | 3.85e-04 | 26 | 21 | 2 | IPR026823 | |
| Domain | cEGF | 3.85e-04 | 26 | 21 | 2 | PF12662 | |
| Domain | Laminin_EGF | 7.01e-04 | 35 | 21 | 2 | PF00053 | |
| Domain | Laminin_EGF | 8.26e-04 | 38 | 21 | 2 | IPR002049 | |
| Domain | - | 3.10e-03 | 74 | 21 | 2 | 3.40.50.410 | |
| Domain | VWFA | 3.79e-03 | 82 | 21 | 2 | PS50234 | |
| Domain | VWA | 3.97e-03 | 84 | 21 | 2 | SM00327 | |
| Domain | VWF_A | 5.47e-03 | 99 | 21 | 2 | IPR002035 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.71e-07 | 258 | 17 | 6 | MM14572 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 6.57e-07 | 15 | 17 | 3 | M27161 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.98e-07 | 300 | 17 | 6 | M610 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.18e-06 | 18 | 17 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.18e-06 | 18 | 17 | 3 | MM14882 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.37e-05 | 5 | 17 | 2 | M27411 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.01e-05 | 140 | 17 | 4 | M587 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 2.05e-05 | 6 | 17 | 2 | M27068 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.76e-05 | 50 | 17 | 3 | MM14796 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 3.82e-05 | 8 | 17 | 2 | M47850 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 5.02e-05 | 61 | 17 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.02e-05 | 61 | 17 | 3 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 6.65e-05 | 67 | 17 | 3 | M26999 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.96e-05 | 68 | 17 | 3 | M27303 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 7.48e-05 | 11 | 17 | 2 | M47865 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 8.97e-05 | 12 | 17 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 8.97e-05 | 12 | 17 | 2 | M47533 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 9.70e-05 | 76 | 17 | 3 | MM14573 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.06e-04 | 13 | 17 | 2 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.06e-04 | 13 | 17 | 2 | M47534 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.60e-04 | 90 | 17 | 3 | M631 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.07e-04 | 18 | 17 | 2 | M614 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 3.72e-04 | 24 | 17 | 2 | M11190 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 4.72e-04 | 27 | 17 | 2 | M39545 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.08e-04 | 28 | 17 | 2 | M6177 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 6.26e-04 | 143 | 17 | 3 | M27275 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.65e-04 | 32 | 17 | 2 | MM14854 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 7.07e-04 | 33 | 17 | 2 | M39870 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 7.51e-04 | 34 | 17 | 2 | M39390 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 8.89e-04 | 37 | 17 | 2 | M27134 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 9.38e-04 | 38 | 17 | 2 | MM14874 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 9.88e-04 | 39 | 17 | 2 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.26e-03 | 44 | 17 | 2 | M26969 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.31e-03 | 45 | 17 | 2 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.37e-03 | 46 | 17 | 2 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.43e-03 | 47 | 17 | 2 | M7946 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.43e-03 | 47 | 17 | 2 | M646 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 2.25e-03 | 59 | 17 | 2 | M39886 | |
| Pathway | PID_NOTCH_PATHWAY | 2.25e-03 | 59 | 17 | 2 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.40e-03 | 61 | 17 | 2 | M39540 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.12e-03 | 250 | 17 | 3 | M27554 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.70e-03 | 76 | 17 | 2 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.80e-03 | 77 | 17 | 2 | MM14670 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 4.30e-03 | 82 | 17 | 2 | MM15922 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.61e-03 | 85 | 17 | 2 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 5.61e-03 | 94 | 17 | 2 | M1041 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 5.96e-03 | 97 | 17 | 2 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 6.44e-03 | 101 | 17 | 2 | M39448 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 8.70e-03 | 118 | 17 | 2 | MM15588 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 8.70e-03 | 118 | 17 | 2 | M39852 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 8.85e-03 | 119 | 17 | 2 | M607 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.45e-02 | 154 | 17 | 2 | M39739 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.58e-02 | 161 | 17 | 2 | M27871 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.58e-02 | 161 | 17 | 2 | M39770 | |
| Pathway | WP_PRIMARY_OVARIAN_INSUFFICIENCY | 1.82e-02 | 174 | 17 | 2 | M48058 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 9.48e-13 | 94 | 28 | 7 | 21542922 | |
| Pubmed | 1.66e-10 | 12 | 28 | 4 | 14557543 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 18824173 | ||
| Pubmed | 1.02e-09 | 18 | 28 | 4 | 18664271 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.87e-09 | 4 | 28 | 3 | 10469592 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 4.67e-09 | 5 | 28 | 3 | 12629516 | |
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 10479448 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.59e-07 | 1201 | 28 | 9 | 35696571 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 33169406 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 8661043 | ||
| Pubmed | Genetic analysis of the contribution of LTBP-3 to thoracic aneurysm in Marfan syndrome. | 6.25e-07 | 2 | 28 | 2 | 26494287 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 7798260 | ||
| Pubmed | Effects of Notch2 and Notch3 on Cell Proliferation and Apoptosis of Trophoblast Cell Lines. | 6.25e-07 | 2 | 28 | 2 | 26640406 | |
| Pubmed | Expression of notch family proteins in placentas from patients with early-onset severe preeclampsia. | 6.25e-07 | 2 | 28 | 2 | 24336671 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 28000152 | ||
| Pubmed | Notch2 and Notch3 function together to regulate vascular smooth muscle development. | 6.25e-07 | 2 | 28 | 2 | 22615991 | |
| Pubmed | LTBP3 Pathogenic Variants Predispose Individuals to Thoracic Aortic Aneurysms and Dissections. | 6.25e-07 | 2 | 28 | 2 | 29625025 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 34257585 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 30306291 | ||
| Pubmed | Enhanced Notch3 signaling contributes to pulmonary emphysema in a Murine Model of Marfan syndrome. | 6.25e-07 | 2 | 28 | 2 | 32616814 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 20658214 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11313359 | ||
| Pubmed | 1.87e-06 | 30 | 28 | 3 | 19054571 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 27847137 | ||
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 1.87e-06 | 3 | 28 | 2 | 29767458 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 7698746 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 27717083 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 10516436 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 25957400 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 10896944 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 7615640 | ||
| Pubmed | Genetic analysis of the role of proteolysis in the activation of latent myostatin. | 1.87e-06 | 3 | 28 | 2 | 18286185 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 7918097 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 8645602 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20043912 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 20301776 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 16507574 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 19079247 | ||
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 1.87e-06 | 3 | 28 | 2 | 21471519 | |
| Pubmed | Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice. | 1.87e-06 | 3 | 28 | 2 | 24419319 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 12808086 | ||
| Pubmed | BMP1 and TLL1 Are Required for Maintaining Periodontal Homeostasis. | 1.87e-06 | 3 | 28 | 2 | 28068493 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 27697639 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 32209430 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 11978185 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 11459941 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 3.75e-06 | 4 | 28 | 2 | 28061457 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 24145721 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 20069356 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 10331975 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 3.75e-06 | 4 | 28 | 2 | 19404845 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 28669409 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 10551863 | ||
| Pubmed | A deficiency of lunatic fringe is associated with cystic dilation of the rete testis. | 3.75e-06 | 4 | 28 | 2 | 18801836 | |
| Pubmed | Mammalian tolloid proteinases: role in growth factor signalling. | 3.75e-06 | 4 | 28 | 2 | 27391803 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 11466531 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 24151014 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 7983737 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 3.75e-06 | 4 | 28 | 2 | 18184405 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 18155189 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 11401408 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 27966788 | ||
| Pubmed | MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells. | 3.75e-06 | 4 | 28 | 2 | 25323858 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 3.75e-06 | 4 | 28 | 2 | 15917835 | |
| Pubmed | Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. | 3.75e-06 | 4 | 28 | 2 | 23999936 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 28084316 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 3.75e-06 | 4 | 28 | 2 | 10194420 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 18156632 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 23444212 | ||
| Pubmed | Functional conservation of mouse Notch receptor family members. | 3.75e-06 | 4 | 28 | 2 | 8898100 | |
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 3.75e-06 | 4 | 28 | 2 | 17920003 | |
| Pubmed | BMP1-like proteinases are essential to the structure and wound healing of skin. | 3.75e-06 | 4 | 28 | 2 | 27363389 | |
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 6.24e-06 | 5 | 28 | 2 | 21726900 | |
| Pubmed | Notch signaling in bulge stem cells is not required for selection of hair follicle fate. | 6.24e-06 | 5 | 28 | 2 | 19211676 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 15076712 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 27040987 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 16899352 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 21124806 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 12393877 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 12242712 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 15882997 | ||
| Pubmed | Assignment of the murine Notch2 and Notch3 genes to chromosomes 3 and 17. | 6.24e-06 | 5 | 28 | 2 | 9570965 | |
| Pubmed | The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways. | 6.24e-06 | 5 | 28 | 2 | 28747678 | |
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 6.24e-06 | 5 | 28 | 2 | 15064243 | |
| Pubmed | A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. | 6.24e-06 | 5 | 28 | 2 | 21562564 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 23675950 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 11101851 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 9111338 | ||
| Pubmed | Expression of Deltex1 during mouse embryogenesis: comparison with Notch1, 2 and 3 expression. | 9.36e-06 | 6 | 28 | 2 | 11731257 | |
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 20870902 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 26062937 | ||
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 9.36e-06 | 6 | 28 | 2 | 19603167 | |
| Pubmed | ALDH maintains the stemness of lung adenoma stem cells by suppressing the Notch/CDK2/CCNE pathway. | 9.36e-06 | 6 | 28 | 2 | 24671051 | |
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 18299578 | ||
| Pubmed | BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. | 9.36e-06 | 6 | 28 | 2 | 17015622 | |
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 9.36e-06 | 6 | 28 | 2 | 12244553 | |
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 22526456 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 9108364 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 9882480 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 9.36e-06 | 6 | 28 | 2 | 15019995 | |
| Interaction | PRG2 interactions | 8.25e-07 | 285 | 24 | 6 | int:PRG2 | |
| Interaction | NTN5 interactions | 2.95e-06 | 24 | 24 | 3 | int:NTN5 | |
| Interaction | CRISP2 interactions | 1.42e-05 | 40 | 24 | 3 | int:CRISP2 | |
| Interaction | ZNF408 interactions | 2.44e-05 | 145 | 24 | 4 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 4.16e-05 | 57 | 24 | 3 | int:ZFP41 | |
| Interaction | LYPD1 interactions | 4.39e-05 | 58 | 24 | 3 | int:LYPD1 | |
| Interaction | OIT3 interactions | 6.18e-05 | 65 | 24 | 3 | int:OIT3 | |
| Interaction | TLL1 interactions | 7.43e-05 | 11 | 24 | 2 | int:TLL1 | |
| Interaction | FCER2 interactions | 7.43e-05 | 11 | 24 | 2 | int:FCER2 | |
| Interaction | ST14 interactions | 9.78e-05 | 207 | 24 | 4 | int:ST14 | |
| Interaction | LY86 interactions | 1.17e-04 | 217 | 24 | 4 | int:LY86 | |
| Interaction | IGSF5 interactions | 1.23e-04 | 14 | 24 | 2 | int:IGSF5 | |
| Interaction | TLL2 interactions | 1.61e-04 | 16 | 24 | 2 | int:TLL2 | |
| Interaction | ZNF146 interactions | 1.68e-04 | 91 | 24 | 3 | int:ZNF146 | |
| Interaction | LTBP1 interactions | 1.74e-04 | 92 | 24 | 3 | int:LTBP1 | |
| Interaction | MAML2 interactions | 1.83e-04 | 17 | 24 | 2 | int:MAML2 | |
| Interaction | MAML3 interactions | 2.55e-04 | 20 | 24 | 2 | int:MAML3 | |
| Interaction | EDN3 interactions | 2.79e-04 | 108 | 24 | 3 | int:EDN3 | |
| Interaction | NOTCH4 interactions | 2.82e-04 | 21 | 24 | 2 | int:NOTCH4 | |
| Interaction | BMP1 interactions | 3.03e-04 | 111 | 24 | 3 | int:BMP1 | |
| Interaction | CASR interactions | 3.09e-04 | 22 | 24 | 2 | int:CASR | |
| Interaction | SCARF2 interactions | 3.69e-04 | 24 | 24 | 2 | int:SCARF2 | |
| Interaction | CFC1 interactions | 4.39e-04 | 126 | 24 | 3 | int:CFC1 | |
| Interaction | SLURP1 interactions | 6.48e-04 | 144 | 24 | 3 | int:SLURP1 | |
| Interaction | MSTN interactions | 7.02e-04 | 33 | 24 | 2 | int:MSTN | |
| Interaction | KLK15 interactions | 7.44e-04 | 151 | 24 | 3 | int:KLK15 | |
| Interaction | HOXA1 interactions | 7.69e-04 | 356 | 24 | 4 | int:HOXA1 | |
| Interaction | SFRP2 interactions | 7.90e-04 | 35 | 24 | 2 | int:SFRP2 | |
| Interaction | WNT10A interactions | 8.82e-04 | 37 | 24 | 2 | int:WNT10A | |
| Interaction | GREM2 interactions | 8.82e-04 | 37 | 24 | 2 | int:GREM2 | |
| Interaction | DLL1 interactions | 9.31e-04 | 38 | 24 | 2 | int:DLL1 | |
| Interaction | IGFBP4 interactions | 1.08e-03 | 41 | 24 | 2 | int:IGFBP4 | |
| Interaction | JAG1 interactions | 1.08e-03 | 41 | 24 | 2 | int:JAG1 | |
| Interaction | LRRIQ1 interactions | 1.19e-03 | 43 | 24 | 2 | int:LRRIQ1 | |
| Cytoband | 11q13.1 | 6.36e-04 | 63 | 27 | 2 | 11q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 1.61e-02 | 330 | 27 | 2 | chr22q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 2.06e-02 | 377 | 27 | 2 | chr21q22 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 9.23e-09 | 6 | 15 | 3 | 894 | |
| GeneFamily | Ankyrin repeat domain containing | 1.67e-02 | 242 | 15 | 2 | 403 | |
| Coexpression | NABA_MATRISOME | 6.06e-07 | 1008 | 21 | 8 | MM17056 | |
| Coexpression | NABA_MATRISOME | 6.93e-07 | 1026 | 21 | 8 | M5889 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.12e-05 | 385 | 21 | 5 | M39264 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL | 1.38e-05 | 402 | 21 | 5 | M45754 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.48e-05 | 191 | 21 | 4 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.64e-05 | 196 | 21 | 4 | M3008 | |
| Coexpression | RAMALHO_STEMNESS_DN | 2.55e-05 | 72 | 21 | 3 | M12763 | |
| Coexpression | RAMALHO_STEMNESS_DN | 3.24e-05 | 78 | 21 | 3 | MM1015 | |
| Coexpression | NABA_ECM_REGULATORS | 3.51e-05 | 238 | 21 | 4 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 3.75e-05 | 242 | 21 | 4 | MM17062 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 4.20e-05 | 85 | 21 | 3 | M45761 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 5.58e-05 | 268 | 21 | 4 | M45796 | |
| Coexpression | NABA_CORE_MATRISOME | 5.74e-05 | 270 | 21 | 4 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 6.16e-05 | 275 | 21 | 4 | M5884 | |
| Coexpression | HELLER_SILENCED_BY_METHYLATION_UP | 6.89e-05 | 283 | 21 | 4 | M8776 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 7.29e-05 | 16 | 21 | 2 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 7.29e-05 | 16 | 21 | 2 | MM1296 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 7.53e-05 | 574 | 21 | 5 | M39056 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 1.22e-04 | 1035 | 21 | 6 | M9898 | |
| Coexpression | DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS | 1.52e-04 | 131 | 21 | 3 | M40316 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.66e-04 | 135 | 21 | 3 | M5825 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 1.68e-04 | 681 | 21 | 5 | M39175 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | 2.18e-04 | 382 | 21 | 4 | M45756 | |
| Coexpression | CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY | 2.62e-04 | 30 | 21 | 2 | M10778 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 2.99e-04 | 32 | 21 | 2 | M5903 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 3.11e-04 | 167 | 21 | 3 | M2395 | |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 3.38e-04 | 34 | 21 | 2 | M14043 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 3.44e-04 | 795 | 21 | 5 | M39050 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 3.74e-04 | 178 | 21 | 3 | M17079 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 4.19e-04 | 185 | 21 | 3 | MM1072 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | 4.48e-04 | 1316 | 21 | 6 | MM1052 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | 4.61e-04 | 465 | 21 | 4 | M9192 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_UP | 5.11e-04 | 198 | 21 | 3 | M4510 | |
| Coexpression | GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP | 5.18e-04 | 199 | 21 | 3 | M6314 | |
| Coexpression | GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP | 5.18e-04 | 199 | 21 | 3 | M7491 | |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN | 5.26e-04 | 200 | 21 | 3 | M8558 | |
| Coexpression | GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP | 5.26e-04 | 200 | 21 | 3 | M7283 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP | 5.26e-04 | 200 | 21 | 3 | M9953 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN | 5.26e-04 | 200 | 21 | 3 | M386 | |
| Coexpression | GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP | 5.26e-04 | 200 | 21 | 3 | M6300 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN | 5.26e-04 | 200 | 21 | 3 | M9637 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 5.26e-04 | 200 | 21 | 3 | M7526 | |
| Coexpression | GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP | 5.26e-04 | 200 | 21 | 3 | M8844 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN | 5.26e-04 | 200 | 21 | 3 | M7993 | |
| Coexpression | GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN | 5.26e-04 | 200 | 21 | 3 | M4889 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 5.26e-04 | 200 | 21 | 3 | M5930 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 5.26e-04 | 200 | 21 | 3 | M5915 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 5.41e-04 | 202 | 21 | 3 | M38982 | |
| Coexpression | KRAS.50_UP.V1_UP | 6.74e-04 | 48 | 21 | 2 | M2878 | |
| Coexpression | ZHOU_TNF_SIGNALING_4HR | 7.32e-04 | 50 | 21 | 2 | M1520 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 8.40e-04 | 235 | 21 | 3 | M5311 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 8.53e-04 | 54 | 21 | 2 | M4737 | |
| Coexpression | HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS | 8.85e-04 | 55 | 21 | 2 | MM397 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_LYMPHATIC_ENDOTHELIAL_CELLS | 1.27e-03 | 66 | 21 | 2 | M40274 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.23e-06 | 466 | 20 | 6 | GSM777050_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_500 | 1.21e-05 | 155 | 20 | 4 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 5.25e-05 | 455 | 20 | 5 | GSM777055_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 5.31e-05 | 456 | 20 | 5 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 6.13e-05 | 783 | 20 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.69e-05 | 240 | 20 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 6.77e-05 | 797 | 20 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.82e-05 | 265 | 20 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K2 | 1.20e-04 | 1298 | 20 | 7 | gudmap_RNAseq_e15.5_Mesangium_2500_K2 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 1.37e-04 | 905 | 20 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.45e-04 | 293 | 20 | 4 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.47e-04 | 337 | 20 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 3.60e-04 | 372 | 20 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 5.08e-04 | 740 | 20 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 6.60e-04 | 437 | 20 | 4 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 6.71e-04 | 439 | 20 | 4 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 7.06e-04 | 445 | 20 | 4 | GSM777043_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 7.36e-04 | 450 | 20 | 4 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 7.55e-04 | 453 | 20 | 4 | GSM777067_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 8.42e-04 | 827 | 20 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | 9.14e-04 | 842 | 20 | 5 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 9.21e-04 | 207 | 20 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSKM - NLT_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.10e-03 | 501 | 20 | 4 | PCBC_ratio_MESO-30_from-OSKM - NLT_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 fibroblast_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.10e-03 | 501 | 20 | 4 | PCBC_ratio_MESO-30 fibroblast_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_plasmid_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.10e-03 | 501 | 20 | 4 | PCBC_ratio_MESO-30_from-plasmid_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.10e-03 | 878 | 20 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.45e-08 | 171 | 21 | 5 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-08 | 173 | 21 | 5 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.09e-08 | 199 | 21 | 5 | 1587d24b19f5bb64a3b6cc1df87c7c472cf41672 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.09e-08 | 199 | 21 | 5 | a9c2041e54899cb8ccc026758647f3ae3ca457dd | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.33e-07 | 134 | 21 | 4 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.33e-07 | 134 | 21 | 4 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.44e-07 | 148 | 21 | 4 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.04e-06 | 167 | 21 | 4 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-06 | 168 | 21 | 4 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-06 | 168 | 21 | 4 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | Endothelial-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.07e-06 | 168 | 21 | 4 | 4977c3837fbb1f36c89fddd5764e37290ac25ad8 | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.09e-06 | 169 | 21 | 4 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 170 | 21 | 4 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 170 | 21 | 4 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 170 | 21 | 4 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 1.20e-06 | 173 | 21 | 4 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-06 | 175 | 21 | 4 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 176 | 21 | 4 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.29e-06 | 176 | 21 | 4 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 1.29e-06 | 176 | 21 | 4 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 176 | 21 | 4 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-06 | 178 | 21 | 4 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 1.38e-06 | 179 | 21 | 4 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.57e-06 | 185 | 21 | 4 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 186 | 21 | 4 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.67e-06 | 188 | 21 | 4 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 1.67e-06 | 188 | 21 | 4 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Endothelial-B|World / lung cells shred on cell class, cell subclass, sample id | 1.67e-06 | 188 | 21 | 4 | 5959a88728812a5f4cbfa54eddc7a73ccbaa2f68 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-06 | 188 | 21 | 4 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 189 | 21 | 4 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-06 | 189 | 21 | 4 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.71e-06 | 189 | 21 | 4 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 189 | 21 | 4 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-06 | 189 | 21 | 4 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 190 | 21 | 4 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 190 | 21 | 4 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 190 | 21 | 4 | f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 190 | 21 | 4 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 190 | 21 | 4 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.78e-06 | 191 | 21 | 4 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.78e-06 | 191 | 21 | 4 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-06 | 191 | 21 | 4 | 9431ffd6b758f756609d9057de2023596e22b5d4 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 191 | 21 | 4 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-06 | 192 | 21 | 4 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-06 | 192 | 21 | 4 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 1.82e-06 | 192 | 21 | 4 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-06 | 192 | 21 | 4 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-06 | 192 | 21 | 4 | 5388f3115ab285f3f3001af1d71543ed64b9e044 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-06 | 193 | 21 | 4 | 09de51f8ac509e03d480ed3dc9dfe7e7defc59cb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-06 | 193 | 21 | 4 | ef007b736da56529ec628fc3df86a335e7ec3f18 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.86e-06 | 193 | 21 | 4 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 194 | 21 | 4 | 76b8512fd92014b3ecc42b0a20d6d1df074cba2c | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-06 | 194 | 21 | 4 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 194 | 21 | 4 | da45811ba07d746e7cba7ed78882b5d98ac7397d | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-06 | 194 | 21 | 4 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-06 | 194 | 21 | 4 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-06 | 194 | 21 | 4 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | facs-BAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 194 | 21 | 4 | ef0fa9daecd3bf43c6cf56345928cacdbee19779 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-06 | 195 | 21 | 4 | c51b1bee79e77aa2ac444a4883ef533c0095eaad | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 195 | 21 | 4 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 195 | 21 | 4 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.93e-06 | 195 | 21 | 4 | 43d372373367b71243c6ea958aedccde4478618f | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 195 | 21 | 4 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.93e-06 | 195 | 21 | 4 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-06 | 195 | 21 | 4 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-06 | 196 | 21 | 4 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-06 | 196 | 21 | 4 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-06 | 196 | 21 | 4 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-06 | 196 | 21 | 4 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-06 | 196 | 21 | 4 | 59b5b5a0c123d0423abd19c312514849004b903b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-06 | 196 | 21 | 4 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-06 | 196 | 21 | 4 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-06 | 197 | 21 | 4 | b16add329bb35a558287ede51353010dde5bc029 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.05e-06 | 198 | 21 | 4 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 198 | 21 | 4 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.05e-06 | 198 | 21 | 4 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 198 | 21 | 4 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.05e-06 | 198 | 21 | 4 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.05e-06 | 198 | 21 | 4 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.05e-06 | 198 | 21 | 4 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-06 | 198 | 21 | 4 | 229588189825b1080181db9515185677b742c668 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 198 | 21 | 4 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.10e-06 | 199 | 21 | 4 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 199 | 21 | 4 | 67f78c070c56e44fba36542041bf7fa1c291807c | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 199 | 21 | 4 | 1ae244b563f85c1ee8d22698f478c842a4d9c7f5 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-06 | 200 | 21 | 4 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-06 | 200 | 21 | 4 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-06 | 200 | 21 | 4 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-06 | 200 | 21 | 4 | c59f262b2b0a7e7dcb2940d1e466f98db6c56625 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-06 | 200 | 21 | 4 | e50ef394e3284a8323bfd60575b262b2be422aea | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-06 | 200 | 21 | 4 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.14e-06 | 200 | 21 | 4 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.14e-06 | 200 | 21 | 4 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.71e-05 | 161 | 21 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.71e-05 | 161 | 21 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.71e-05 | 161 | 21 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-05 | 162 | 21 | 3 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.81e-05 | 162 | 21 | 3 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.92e-05 | 163 | 21 | 3 | 1c014e373667be290d7fb5d24c06c6f313ac8fa3 | |
| ToppCell | Endothelial-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 6.14e-05 | 165 | 21 | 3 | b6893882472aeb0d18e26f47eaec9d53688afcde | |
| Computational | Developmental processes. | 6.44e-05 | 333 | 15 | 5 | MODULE_220 | |
| Drug | gamma-secretase inhibitor I | 5.34e-06 | 4 | 22 | 2 | CID011754711 | |
| Drug | pyrachlostrobin | 7.57e-06 | 811 | 22 | 7 | ctd:C513428 | |
| Drug | vgBE | 1.33e-05 | 6 | 22 | 2 | CID000193461 | |
| Drug | MW167 | 1.87e-05 | 7 | 22 | 2 | CID010312597 | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; HL60; HT_HG-U133A | 3.31e-05 | 194 | 22 | 4 | 2180_UP | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A | 3.38e-05 | 195 | 22 | 4 | 5840_DN | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; HL60; HT_HG-U133A | 3.59e-05 | 198 | 22 | 4 | 6137_DN | |
| Drug | GDP-fucose | 3.77e-05 | 68 | 22 | 3 | CID000000451 | |
| Drug | nitrofen | 7.87e-05 | 87 | 22 | 3 | CID000015787 | |
| Drug | Ta 3 | 8.05e-05 | 14 | 22 | 2 | CID000027110 | |
| Disease | Glioblastoma Multiforme | 1.32e-06 | 111 | 22 | 4 | C1621958 | |
| Disease | Geleophysic dysplasia | 5.30e-06 | 5 | 22 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 5.30e-06 | 5 | 22 | 2 | C0265287 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.11e-05 | 7 | 22 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.11e-05 | 7 | 22 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | intraocular pressure measurement | 3.09e-05 | 509 | 22 | 5 | EFO_0004695 | |
| Disease | brain cancer (implicated_via_orthology) | 1.71e-04 | 26 | 22 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 2.28e-04 | 30 | 22 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.60e-04 | 32 | 22 | 2 | DOID:10155 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGQGGRREDGGPACY | 26 | Q9H6X2 | |
| PCGANGRCRSREGGY | 1371 | Q9NYQ6 | |
| RPCGCCSYVGRRGGG | 181 | P13497 | |
| GGVQERGVFCPGGLC | 1441 | P58397 | |
| GLGRQGLGCDACGYF | 901 | Q6DT37 | |
| NGGTCANRNGGYGCV | 311 | Q04721 | |
| RPCGGYGQCEGEGTR | 161 | Q96HD1 | |
| GCGCGSFRRLGYGCG | 26 | Q3LI73 | |
| GGQPVCRGGTQRPCY | 36 | Q6UX15 | |
| QPCQHGGTCRGYMGG | 1091 | Q9UM47 | |
| YGCYCGQEGRGEPRD | 326 | Q02509 | |
| GRCVCDRGFGGPYCV | 1781 | P78509 | |
| CERYNGQVCGGPGRG | 541 | P05107 | |
| GGQVRTFGGKCYNCG | 536 | P87889 | |
| GGQVRTFGGKCYNCG | 536 | Q9YNA8 | |
| GGQVRTFGGKCYNCG | 536 | P62683 | |
| GGQVRTFGGKCYNCG | 536 | P63145 | |
| GGQVRTFGGKCYNCG | 536 | P63130 | |
| GGQVRTFGGKCYNCG | 536 | P62685 | |
| GGQVRTFGGKCYNCG | 536 | P63126 | |
| GGQVRTFGGKCYNCG | 536 | P62684 | |
| GNGQCLNAPGGYRCE | 1416 | P35555 | |
| CGPGYQRRPDGEGCV | 2276 | P35555 | |
| QPGYRSQGGGACRDV | 731 | Q9NS15 | |
| CQGDGYRIGFGQCAG | 396 | P16930 | |
| GCCSYVGRRGNGPQA | 211 | O43897 | |
| VGGCRCQPGYQPARG | 296 | O15197 | |
| GGQVRTFGGKCYNCG | 536 | P63128 | |
| TCGCCSYVGRRGGGP | 211 | Q9Y6L7 | |
| YGSYQGRCVICGGPG | 51 | Q7RTV0 | |
| YPDQGGVCQGTCVGG | 301 | Q9Y6Q6 | |
| GVCQGTCVGGGPYAQ | 306 | Q9Y6Q6 |